Beta-amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Vogelgesang, Silke ^a   Brenn, Anja ^a   Grube, Markus ^a   Peters, Michele ^a   Fischer, Andrea ^a   Jedlitschky, Gabriele ^a   Kroemer, Heyo K ^a   Warzok, Rolf W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GLYCOPROTEIN P; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOWN REGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

EID: 80052672466     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/690121     Document Type: Article

References (28)

1. Zlokovic B. V., Neurovascular mechanisms of Alzheimer's neurodegeneration Trends in Neurosciences 2005 28 4 202 208 (Pubitemid 40445527)
2. Iadecola C., The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia Acta Neuropathologica 2010 120 3 287 296
3. Deane R., Bell R. D., Sagare A., Zlokovic B. V., Clearance of amyloid- peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease CNS and Neurological Disorders Drug Targets 2009 8 1 16 30
4. Shibata M., Yamada S., Kumar S. R., Calero M., Bading J., Frangione B., Holtzman D. M., Miller C. A., Strickland D. K., Ghiso J., Zlokovic B. V., Clearance of Alzheimer's amyloid-ss(140) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier Journal of Clinical Investigation 2000 106 12 1489 1499 (Pubitemid 32038587)
5. Deane R., Sagare A., Zlokovic B. V., The role of the cell surface LRP and soluble LRP in blood-brain barrier A clearance in Alzheimer's disease Current Pharmaceutical Design 2008 14 16 1601 1605 (Pubitemid 352002987)
6. Deane R., Du Y. S., Submamaryan R. K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A. M., Armstrong D. L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B., RAGE mediates amyloid- peptide transport across the blood-brain barrier and accumulation in brain Nature Medicine 2003 9 7 907 913 (Pubitemid 36889934)
7. Deane R., Wu Z., Zlokovic B. V., RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid -peptide clearance through transport across the blood-brain barrier Stroke 2004 35 11 2628 2631 (Pubitemid 39458354)
8. Lee G., Bendayan R., Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders Pharmaceutical Research 2004 21 8 1313 1330 (Pubitemid 39149646)
9. Lam F. C., Liu R., Lu P., Shapiro A. B., Renoir J. M., Sharom F. J., Reiner P. B., α-amyloid efflux mediated by p-glycoprotein Journal of Neurochemistry 2001 76 4 1121 1128
10. Vogelgesang S., Cascorbi I., Schroeder E., Pahnke J., Kroemer H. K., Siegmund W., Kunert-Keil C., Walker L. C., Warzok R. W., Deposition of Alzheimer's -amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics 2002 12 7 535 541 (Pubitemid 35177083)
11. Vogelgesang S., Warzok R. W., Cascorbi I., Kunert-Keil C., Schroeder E., Kroemer H. K., Siegmund W., Walker L. C., Pahnke J., The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease Current Alzheimer Research 2004 1 2 121 125
12. Kuhnke D., Jedlitschky G., Grube M., Krohn M., Jucker M., Mosyagin I., Cascorbi I., Walker L. C., Kroemer H. K., Warzok R. W., Vogelgesang S., MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid- peptidesimplications for the mechanisms of A clearance at the blood-brain barrier Brain Pathology 2007 17 4 347 353 (Pubitemid 47537591)
13. Cirrito J. R., Deane R., Fagan A. M., Spinner M. L., Parsadanian M., Finn M. B., Jiang H., Prior J. L., Sagare A., Bales K. R., Paul S. M., Zlokovic B. V., Piwnica-Worrns D., Holtzman D. M., P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model Journal of Clinical Investigation 2005 115 11 3285 3290 (Pubitemid 41567593)
14. Hartz A. M. S., Miller D. S., Bauer B., Restoring blood-brain barrier P-glycoprotein reduces brain amyloid- in a mouse model of Alzheimer's disease Molecular Pharmacology 2010 77 5 715 723
15. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H. W., Spijkers P., Guo H., Song X., Lenting P. J., Van Nostrand W. E., Zlokovic B. V., LRP/amyloid -peptide interaction mediates differential brain efflux of A isoforms Neuron 2004 43 3 333 344 (Pubitemid 39061126)
16. Donahue J. E., Flaherty S. L., Johanson C. E., Duncan J. A., Silverberg G. D., Miller M. C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E. G., RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease Acta Neuropathologica 2006 112 4 405 415 (Pubitemid 44469161)
17. Zlokovic B. V., New therapeutic targets in the neurovascular pathway in Alzheimer's disease Neurotherapeutics 2008 5 3 409 414 (Pubitemid 351952489)
18. Silverberg G. D., Messier A. A., Miller M. C., Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging Journal of Neuropathology Experimental Neurology 2010 69 10 1034 1043
19. Irie K., Murakami K., Masuda Y., Morimoto A., Ohigashi H., Ohashi R., Takegoshi K., Nagao M., Shimizu T., Shirasawa T., Structure of -amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease Journal of Bioscience and Bioengineering 2005 99 5 437 447 (Pubitemid 40874521)
20. Carte M. D., Simms G. A., Weaver D. F., The development of new therapeutics for Alzheimer's disease Clinical Pharmacology Therapeutics 2010 88 4 475 486
21. Butterfield D. A., Amyloid -peptide [142]-assosiated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences Current Medicinal Chemistry 2003 10 24 2651 2659 (Pubitemid 37456035)
22. Nicolazzo J. A., Katneni K., Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2) Current Topics in Medicinal Chemistry 2009 9 2 130 147
23. Robey R. W., To K. K., Polgar O., Dohse M., Fetsch P., Dean M., Bates S. E., ABCG2: a perspective Advanced Drug Delivery Reviews 2009 61 1 3 13
24. Tai L. M., Loughlin A. J., Male D. K., Romero I. A., P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-β Journal of Cerebral Blood Flow and Metabolism 2009 29 6 1079 1083
25. Xiong H., Callaghan D., Jones A., Bai J., Rasquinha I., Smith C., Pei KE., Walker D., Lue L. F., Stanimirovic D., Zhang W., ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for A (140) peptides Journal of Neuroscience 2009 29 17 5463 5475
26. Tan B., Piwnica-Worms D., Ratner L., Multidrug resistance transporters and modulation Current Opinion in Oncology 2000 12 5 450 458 (Pubitemid 32268882)
27. Asghar A., Gorski J. C., Haehner-Daniels B., Hall S. D., Induction of multidrug resistance-1 and cytochrome P450 mRNAS in human mononuclear cells by rifampin Drug Metabolism and Disposition 2002 30 1 20 26 (Pubitemid 34016936)
28. Jedlitschky G., Vogelgesang S., Kroemer H. K., MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid- peptides: implications for the pathogenesis and therapy of Alzheimer's disease Clinical Pharmacology Therapeutics 2010 88 4 441 443